KaryoLogic

Durham, United States Founded: 2008 • Age: 18 yrs Acquired By Clean Cells
Company offers karyotyping and digital PCR services for human, mouse, and rare species, stem cell and cancer cell lines
Request Access

About KaryoLogic

KaryoLogic is a company based in Durham (United States) founded in 2008 was acquired by Clean Cells in April 2025.. KaryoLogic offers products and services including Human Stem Cell Karyotyping and Digital PCR, Human Non-Stem Cell Karyotyping, Non-Human Species Karyotyping, and Fluorescence In Situ Hybridization. KaryoLogic operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.

  • Headquarter Durham, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Karyologic, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Clean Cells

    (Apr 08, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of KaryoLogic

KaryoLogic offers a comprehensive portfolio of products and services, including Human Stem Cell Karyotyping and Digital PCR, Human Non-Stem Cell Karyotyping, Non-Human Species Karyotyping, and Fluorescence In Situ Hybridization. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Analyzes chromosomes in human stem cells for research integrity

Performs chromosome analysis on human non-stem cells

Offers karyotyping for animal and other species

Detects specific DNA sequences in chromosomes

Funding Insights of KaryoLogic

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in KaryoLogic

KaryoLogic has secured backing from 1 investor. Prominent investors backing the company include Clean Cells. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Offers cell banking and virus banking services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by KaryoLogic

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - KaryoLogic

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Karyologic Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of KaryoLogic

KaryoLogic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of drug discovery and preclinical development services
domain founded_year HQ Location
Provider of laboratory tests for physicians
domain founded_year HQ Location
Data analysis and statistical solutions are provided for life sciences.
domain founded_year HQ Location
Provider of clinical research, development, and commercialization services for life sciences
domain founded_year HQ Location
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
domain founded_year HQ Location
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Karyologic

Frequently Asked Questions about KaryoLogic

When was KaryoLogic founded?

KaryoLogic was founded in 2008.

Where is KaryoLogic located?

KaryoLogic is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

What does KaryoLogic do?

KaryoLogic offers karyotyping services for human, mouse, and rare species, stem cell and cancer cell lines, as well as digital PCR services for human stem cells. They accept cell samples shipped from around the globe to their North Carolina USA location for high quality karyotyping services. KaryoLogic has also partnered with other biotech companies to improve their services.

Who are the top competitors of KaryoLogic?

KaryoLogic's top competitors include LabCorp, Charles River Laboratories and Cytel.

What products or services does KaryoLogic offer?

KaryoLogic offers Human Stem Cell Karyotyping and Digital PCR, Human Non-Stem Cell Karyotyping, Non-Human Species Karyotyping, and Fluorescence In Situ Hybridization.

Who are KaryoLogic's investors?

KaryoLogic has 1 investor. Key investors include Clean Cells.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available